These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1699199)

  • 1. The Evi-1 zinc finger myeloid transforming gene is normally expressed in the kidney and in developing oocytes.
    Morishita K; Parganas E; Parham DM; Matsugi T; Ihle JN
    Oncogene; 1990 Sep; 5(9):1419-23. PubMed ID: 1699199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Evi-1 zinc finger myeloid transforming protein binds to genomic fragments containing (GATA)n sequences.
    Matsugi T; Kreider BL; Delwel R; Cleveland JL; Askew DS; Ihle JN
    Oncogene; 1995 Jul; 11(1):191-8. PubMed ID: 7624127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The carboxyl domain of zinc fingers of the Evi-1 myeloid transforming gene binds a consensus sequence of GAAGATGAG.
    Funabiki T; Kreider BL; Ihle JN
    Oncogene; 1994 Jun; 9(6):1575-81. PubMed ID: 8183551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human Evi-1 gene is located on chromosome 3q24-q28 but is not rearranged in three cases of acute nonlymphocytic leukemias containing t(3;5)(q25;q34) translocations.
    Morishita K; Parganas E; Bartholomew C; Sacchi N; Valentine MB; Raimondi SC; Le Beau MM; Ihle JN
    Oncogene Res; 1990; 5(3):221-31. PubMed ID: 2108405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal expression of Evi-1 gene in human leukemias.
    Ogawa S; Mitani K; Kurokawa M; Matsuo Y; Minowada J; Inazawa J; Kamada N; Tsubota T; Yazaki Y; Hirai H
    Hum Cell; 1996 Dec; 9(4):323-32. PubMed ID: 9183665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unique expression of the human Evi-1 gene in an endometrial carcinoma cell line: sequence of cDNAs and structure of alternatively spliced transcripts.
    Morishita K; Parganas E; Douglass EC; Ihle JN
    Oncogene; 1990 Jul; 5(7):963-71. PubMed ID: 2115646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of two alternatively spliced evi-1 proto-oncogene transcripts by cAMP in kidney cells.
    Bartholomew C; Clark AM
    Oncogene; 1994 Mar; 9(3):939-42. PubMed ID: 8108138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the zinc finger gene EVI-1 in ovarian and other cancers.
    Brooks DJ; Woodward S; Thompson FH; Dos Santos B; Russell M; Yang JM; Guan XY; Trent J; Alberts DS; Taetle R
    Br J Cancer; 1996 Nov; 74(10):1518-25. PubMed ID: 8932329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evi-1 expression in Xenopus.
    Mead PE; Parganas E; Ohtsuka S; Morishita K; Gamer L; Kuliyev E; Wright CV; Ihle JN
    Gene Expr Patterns; 2005 Jun; 5(5):601-8. PubMed ID: 15905132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evi-1 ZF1 DNA binding activity and a second distinct transcriptional repressor region are both required for optimal transformation of Rat1 fibroblasts.
    Kilbey A; Bartholomew C
    Oncogene; 1998 Apr; 16(17):2287-91. PubMed ID: 9619838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Evi-1 proto-oncogene encodes a transcriptional repressor activity associated with transformation.
    Bartholomew C; Kilbey A; Clark AM; Walker M
    Oncogene; 1997 Feb; 14(5):569-77. PubMed ID: 9053855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The AML1/Evi-1 fusion protein in the t(3;21) translocation exhibits transforming activity on Rat1 fibroblasts with dependence on the Evi-1 sequence.
    Kurokawa M; Ogawa S; Tanaka T; Mitani K; Yazaki Y; Witte ON; Hirai H
    Oncogene; 1995 Sep; 11(5):833-40. PubMed ID: 7675444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retroviral insertions 90 kilobases proximal to the Evi-1 myeloid transforming gene activate transcription from the normal promoter.
    Bartholomew C; Ihle JN
    Mol Cell Biol; 1991 Apr; 11(4):1820-8. PubMed ID: 1848663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structurally altered Evi-1 protein generated in the 3q21q26 syndrome.
    Ogawa S; Kurokawa M; Tanaka T; Mitani K; Inazawa J; Hangaishi A; Tanaka K; Matsuo Y; Minowada J; Tsubota T; Yazaki Y; Hirai H
    Oncogene; 1996 Jul; 13(1):183-91. PubMed ID: 8700545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms of leukemogenesis by AML1/EVI-1.
    Mitani K
    Oncogene; 2004 May; 23(24):4263-9. PubMed ID: 15156182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between Evi-1 expression and mouse ovarian follicular development.
    Li Y; Zhang C
    Acta Histochem; 2012 Feb; 114(2):79-86. PubMed ID: 21397932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retroviral insertional activation of the EVI1 oncogene does not prevent G-CSF-induced maturation of the murine pluripotent myeloid cell line 32Dcl3.
    Khanna-Gupta A; Lopingco MC; Savinelli T; Zibello T; Berliner N; Perkins AS
    Oncogene; 1996 Feb; 12(3):563-9. PubMed ID: 8637713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the Evi-1 zinc finger gene in 32Dc13 myeloid cells blocks granulocytic differentiation in response to granulocyte colony-stimulating factor.
    Morishita K; Parganas E; Matsugi T; Ihle JN
    Mol Cell Biol; 1992 Jan; 12(1):183-9. PubMed ID: 1370341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The oncoprotein Evi-1 represses TGF-beta signalling by inhibiting Smad3.
    Kurokawa M; Mitani K; Irie K; Matsuyama T; Takahashi T; Chiba S; Yazaki Y; Matsumoto K; Hirai H
    Nature; 1998 Jul; 394(6688):92-6. PubMed ID: 9665135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of the LAZ3 (BCL6) proto-oncogene accompanies murine skeletal myogenesis.
    Albagli-Curiel O; Dhordain P; Lantoine D; Auradé F; Quief S; Kerckaert JP; Montarras D; Pinset C
    Differentiation; 1998 Nov; 64(1):33-44. PubMed ID: 9921651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.